Diagnostic groups are formed according to the proposed model where AD pathogenesis develops as sequential cascade of events initiated by Aβ42 pathology, followed by tau pathology and subsequent cortical glucose hypometabolism and neurodegeneration (Jack et al., 2013). This evidence concerns the gene MAPT and Alzheimer disease.